About the Wellcome Trust

A healthier future for everyone

The Wellcome Genome Campus is an asset of the Wellcome Trust, a global charitable foundation established in 1936.

Wellcome Trust is driving advances in genomics, infectious disease, mental health and climate and health. These strategic programmes have a strong focus on global partnerships, equitable access and real-world impact.

Between 2022 and 2032, Wellcome Trust plans to spend £16bn on its programmes. It has spent £5.2bn over the first three years of its plan. The Trust mission is funded by returns from a portfolio of financial investments. WGC Group, the Wellcome Genome Campus and its expansion are part of that portfolio.

Between 2022 and 2032, the Trust will spend £16 billion driving advances in:

Genomics

Focused on the Human Cell Atlas and Darwin Tree

Infectious diseases

Focused on the most pressing vaccine and treatment development

Mental health

Focused on early intervention with a global, inclusive approach

Climate & health

Focused on putting health at the centre of climate action

06 Contact